{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T23:38:36Z","timestamp":1778369916359,"version":"3.51.4"},"reference-count":133,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz","award":["503\/3-015-02\/503-31-001-19-00"],"award-info":[{"award-number":["503\/3-015-02\/503-31-001-19-00"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>The global scope and scale of the SARS-CoV-2 pandemic led to huge amounts of important data from clinical observations and experimental analyses being collected, in particular, regarding the long-term impact of COVID-19 on lung tissue. Visible changes in lung tissue mainly relate to the destruction of the alveolar architecture, dense cellularity, and pulmonary fibrosis with myofibroblast proliferation and collagen deposition. These changes are the result of infection, mainly with virus variants from the first pandemic waves (Alpha to Delta). In addition, proper regulation of immune responses to pathogenic viral stimuli is critical for the control of and recovery from tissue\/organ damage, including in the lungs. We can distinguish three main processes in the lungs during SARS-CoV-2 infection: damage or deficiency of the pulmonary surfactant, coagulation processes, and fibrosis. Understanding the molecular basis of these processes is extremely important in the context of elucidating all pathologies occurring after virus entry. In the present review, data on the abovementioned three biochemical processes that lead to pathological changes are gathered together and discussed. Systematization of the knowledge is necessary to explore the three key pathways in lung tissue after SARS-CoV-2 virus infection as a result of a prolonged and intense inflammatory process in the context of pulmonary fibrosis, hemostatic disorders, and disturbances in the structure and\/or metabolism of the surfactant. Despite the fact that the new Omicron variant does not affect the lungs as much as the previous variants, we cannot ignore the fact that other new mutations and emerging variants will not cause serious damage to the lung tissue. In the future, this review will be helpful to stratify the risk of serious complications in patients, to improve COVID-19 treatment outcomes, and to select those who may develop complications before clinical manifestation.<\/jats:p>","DOI":"10.3390\/biom12121845","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T02:15:33Z","timestamp":1670811333000},"page":"1845","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients"],"prefix":"10.3390","volume":"12","author":[{"given":"Adrian","family":"Krygier","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9524-6032","authenticated-orcid":false,"given":"Dagmara","family":"Szmajda-Krygier","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafa\u0142","family":"\u015awiechowski","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9187-1199","authenticated-orcid":false,"given":"Jacek","family":"Pietrzak","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1732-0233","authenticated-orcid":false,"given":"Agnieszka","family":"Wosiak","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damian","family":"Wodzi\u0144ski","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5257-2914","authenticated-orcid":false,"given":"Ewa","family":"Balcerczak","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.arbres.2021.08.014","article-title":"Lung function, radiological findings and biomarkers of fibrogenesis in a cohort of COVID-19 patients six months after hospital discharge","volume":"58","author":"Safont","year":"2022","journal-title":"Arch. Bronconeumol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s10753-022-01656-7","article-title":"SARS-Cov-2 infection: Host response, immunity, and therapeutic targets","volume":"45","author":"Shivshankar","year":"2022","journal-title":"Inflammation"},{"key":"ref_3","unstructured":"(2022, October 19). \u201cCOVID-19 Map.\u201d Johns Hopkins Coronavirus Resource Center. Available online: https:\/\/coronavirus.jhu.edu\/map.html."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41577-021-00522-1","article-title":"The first 12 months of COVID-19: A timeline of immunological insights","volume":"21","author":"Carvalho","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","article-title":"Attributes and predictors of long COVID","volume":"27","author":"Sudre","year":"2021","journal-title":"Nat. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.semcancer.2021.01.003","article-title":"Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19","volume":"83","author":"Ahmad","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"19395","DOI":"10.1038\/s41598-020-76404-8","article-title":"Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy","volume":"10","author":"Islam","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"874307","DOI":"10.3389\/fmed.2022.874307","article-title":"Pathological findings associated with SARS-Cov-2 on postmortem core biopsies: Correlation with clinical presentation and disease course","volume":"9","author":"Alenda","year":"2022","journal-title":"Front. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1080\/07853890.2022.2039954","article-title":"COVID-19-related end stage lung disease: Two distinct phenotypes","volume":"54","author":"Kostopanagiotou","year":"2022","journal-title":"Ann. Med."},{"key":"ref_11","first-page":"103590","article-title":"Post COVID-19 pulmonary fibrosis; a meta-analysis study","volume":"77","author":"Kakamad","year":"2022","journal-title":"Ann. Med. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Haslbauer, J.D., Bratic-Hench, I., Cima, K., Luger, A.K., Schmitz, K., Augustin, F., Krapf, C., Hoefer, D., Tancevski, I., and Tzankov, A. (2022). Interstitial pulmonary fibrosis and extensive dendriform ossification with persistent viral load: A rare presentation of post-COVID-19 condition in need of lung transplantation. Pathobiology, ahead of print.","DOI":"10.1159\/000525457"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"114812","DOI":"10.1016\/j.bcp.2021.114812","article-title":"Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: Lessons from post-COVID-19 patients","volume":"193","author":"Giacomelli","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"210194","DOI":"10.1183\/16000617.0194-2021","article-title":"Recovering from a pandemic: Pulmonary fibrosis after SARS-Cov-2 infection","volume":"30","author":"Mylvaganam","year":"2021","journal-title":"Eur. Respir. Rev. Off. J. Eur. Respir. Soc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.resinv.2022.08.001","article-title":"Comparison of COVID-19 pneumonia during the SARS-Cov-2 Omicron wave and the previous non-Omicron wave in a single facility","volume":"60","author":"Ito","year":"2022","journal-title":"Respir. Investig."},{"key":"ref_17","unstructured":"(2022, November 18). Classification of Omicron (B.1.1.529): SARS-Cov-2 Variant of Concern. Available online: https:\/\/www.who.int\/news\/item\/26-11-2021-classification-of-omicron-(b.1.1.529)-SARS-Cov-2-variant-of-concern."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","article-title":"Early assessment of the clinical severity of the SARS-Cov-2 omicron variant in South Africa: A data linkage study","volume":"399","author":"Wolter","year":"2022","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4329\/wjr.v13.i10.327","article-title":"COVID-19 pneumonia: A review of typical radiological characteristics","volume":"13","author":"Churruca","year":"2021","journal-title":"World J. Radiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","article-title":"SARS-Cov-2 Omicron variant replication in human bronchus and lung ex vivo","volume":"603","author":"Hui","year":"2022","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/jmv.27588","article-title":"Omicron variant of SARS-Cov-2: Genomics, transmissibility, and responses to current COVID-19 vaccines","volume":"94","author":"Araf","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"100169","DOI":"10.1016\/j.opresp.2022.100169","article-title":"Evolution and Clinical Trend of SARS-Cov-2 Variants [Evoluci\u00f3n y tendencia cl\u00ednica de las variantes del SARS-Cov-2]","volume":"4","author":"Landete","year":"2022","journal-title":"Open Respir. Arch."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fmed.2020.00254","article-title":"Lung surfactant for pulmonary barrier restoration in patients with COVID-19 pneumonia","volume":"7","author":"Mirastschijski","year":"2020","journal-title":"Front. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"210077","DOI":"10.1183\/16000617.0077-2021","article-title":"Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure","volume":"30","author":"Milad","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.bbamem.2010.03.008","article-title":"Pulmonary surfactant layers accelerate o2 diffusion through the air-water interface","volume":"1798","author":"Olmeda","year":"2010","journal-title":"Biochim. Et Biophys. Acta (BBA)-Biomembr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1164\/ajrccm.156.2.9609092","article-title":"Ultrasonic nebulization for efficient delivery of surfactant in a model of acute lung injury","volume":"156","author":"Schermuly","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_27","first-page":"139","article-title":"The effect of a peptide-containing synthetic lung surfactant on gas exchange and lung mechanics in a rabbit model of surfactant depletion","volume":"7","author":"Smith","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1203\/00006450-199805000-00016","article-title":"Protein composition of synthetic surfactant affects gas exchange in surfactant-deficient rats","volume":"43","author":"Walther","year":"1998","journal-title":"Pediatr. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1099-0496(199803)25:3<196::AID-PPUL10>3.0.CO;2-1","article-title":"Rate of surfactant administration influences lung function and gas exchange in a surfactant-deficient rabbit model","volume":"25","author":"Krause","year":"1998","journal-title":"Pediatr. Pulmonol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.33549\/physiolres.934763","article-title":"Alveolar type ii cells and pulmonary surfactant in COVID-19 era","volume":"70","author":"Calkovska","year":"2021","journal-title":"Physiol. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"C991","DOI":"10.1152\/ajpcell.00341.2020","article-title":"Heterogeneous groups of alveolar type ii cells in lung homeostasis and repair","volume":"319","author":"Chen","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1165\/rcmb.2016-0426PS","article-title":"When is an alveolar type 2 cell an alveolar type 2 cell? A conundrum for lung stem cell biology and regenerative medicine","volume":"57","author":"Beers","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1096\/fj.201701462RR","article-title":"Pulmonary surfactant protein sp-b promotes exocytosis of lamellar bodies in alveolar type ii cells","volume":"32","author":"Olmeda","year":"2018","journal-title":"FASEB J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1378\/chest.15-1353","article-title":"Antimicrobial peptides and innate lung defenses","volume":"149","author":"Hiemstra","year":"2016","journal-title":"Chest"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1515\/tsd-2021-2382","article-title":"Surfactant-based therapy against COVID-19: A review","volume":"58","author":"Rahaman","year":"2021","journal-title":"Tenside Surfactants Deterg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1183\/20734735.006513","article-title":"Pulmonary surfactant in newborn infants and children","volume":"9","author":"Chakraborty","year":"2013","journal-title":"Breathe"},{"key":"ref_37","first-page":"5","article-title":"Pulmonary surfactants and their role in pathophysiology of lung disorders","volume":"51","author":"Akella","year":"2013","journal-title":"Indian J. Exp. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1038\/s41598-018-28005-9","article-title":"Sfta3\u2014A novel surfactant protein of the ocular surface and its role in corneal wound healing and tear film surface tension","volume":"8","author":"Schicht","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.aanat.2016.07.005","article-title":"The importance of surfactant proteins\u2014New aspects on macrophage phagocytosis","volume":"208","author":"Tschernig","year":"2016","journal-title":"Ann. Anat.-Anat. Anz."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Mittal, R.A., Hammel, M., Schwarz, J., Heschl, K.M., Bretschneider, N., Flemmer, A.W., Herber-Jonat, S., K\u00f6nigshoff, M., Eickelberg, O., and Holzinger, A. (2012). Sfta2\u2014A novel secretory peptide highly expressed in the lung--is modulated by lipopolysaccharide but not hyperoxia. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0040011"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Diler, E., Schicht, M., Rabung, A., Tschernig, T., Meier, C., Rausch, F., Garreis, F., Br\u00e4uer, L., and Paulsen, F. (2014). The novel surfactant protein sp-h enhances the phagocytosis efficiency of macrophage-like cell lines u937 and mh-s. BMC Res. Notes, 7.","DOI":"10.1186\/1756-0500-7-851"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.9734\/arrb\/2020\/v35i630233","article-title":"Role of surfactant for the treatment of alveolar cells against coronavirus (COVID-19)","volume":"35","author":"Ahmed","year":"2020","journal-title":"Annu. Res. Rev. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"101413","DOI":"10.1016\/j.cocis.2020.101413","article-title":"Exogenous pulmonary surfactant: A review focused on adjunctive therapy for severe acute respiratory syndrome coronavirus 2 including sp-a and sp-d as added clinical marker","volume":"51","author":"Ghati","year":"2021","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"698905","DOI":"10.3389\/fphar.2021.698905","article-title":"The role of pulmonary surfactants in the treatment of acute respiratory distress syndrome in COVID-19","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"L115","DOI":"10.1152\/ajplung.00126.2020","article-title":"Thoughts on the alveolar phase of COVID-19","volume":"319","author":"Mason","year":"2020","journal-title":"Am. J. Physiology. Lung Cell. Mol. Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.pulmoe.2020.10.013","article-title":"Respiratory function in patients post-infection by COVID-19: A systematic review and meta-analysis","volume":"27","author":"Burgos","year":"2021","journal-title":"Pulmonology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13054-018-2051-8","article-title":"Acute lung injury: How to stabilize a broken lung","volume":"22","author":"Nieman","year":"2018","journal-title":"Crit. Care (London Engl.)"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1038\/s41598-022-07944-4","article-title":"Reduced levels of pulmonary surfactant in COVID-19 ards","volume":"12","author":"Schousboe","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"110020","DOI":"10.1016\/j.mehy.2020.110020","article-title":"Pulmonary surfactant itself must be a strong defender against SARS-Cov-2","volume":"144","author":"Takano","year":"2020","journal-title":"Med. Hypotheses"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2004165","DOI":"10.1183\/13993003.04165-2020","article-title":"Collapse induration of alveoli is an ultrastructural finding in a COVID-19 patient","volume":"57","author":"Ochs","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3389\/fmicb.2020.01905","article-title":"Severity of coronavirus disease 2019 (COVID-19): Does surfactant matter?","volume":"11","author":"Weiskirchen","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"106114","DOI":"10.1016\/j.rmed.2020.106114","article-title":"Pharmacological management of COVID-19 patients with ards (cards): A narrative review","volume":"171","author":"Matera","year":"2020","journal-title":"Respir. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bbrc.2006.03.158","article-title":"The ttf-1\/tap26 complex differentially modulates surfactant protein-b (sp-b) and -c (sp-c) promoters in lung cells","volume":"344","author":"Yang","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1074\/jbc.275.2.1043","article-title":"Gata-6 activates transcription of surfactant protein a","volume":"275","author":"Bruno","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.gene.2012.09.111","article-title":"Genetic complexity of the human surfactant-associated proteins sp-a1 and sp-a2","volume":"531","author":"Silveyra","year":"2013","journal-title":"Gene"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0014-5793(01)03056-3","article-title":"Abca3 is a lamellar body membrane protein in human lung alveolar type ii cells","volume":"508","author":"Yamano","year":"2001","journal-title":"FEBS Lett."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Fassan, M., Collesei, A., Angerilli, V., Sbaraglia, M., Fortarezza, F., Pezzuto, F., de Gaspari, M., Businello, G., Moni, M., and Rizzo, S. (2022). Multi-design differential expression profiling of COVID-19 lung autopsy specimens reveals significantly deregulated inflammatory pathways and sftpc impaired transcription. Cells, 11.","DOI":"10.3390\/cells11061011"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fmed.2018.00018","article-title":"Surfactant protein d in respiratory and non-respiratory diseases","volume":"5","author":"Sorensen","year":"2018","journal-title":"Front. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e589","DOI":"10.1016\/S2214-109X(15)00183-7","article-title":"New who recommendations to improve the outcomes of preterm birth","volume":"3","author":"Vogel","year":"2015","journal-title":"Lancet Glob. Health"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"842453","DOI":"10.3389\/fimmu.2022.842453","article-title":"Insights gained into the treatment of COVID-19 by pulmonary surfactant and its components","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in china, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, china: A descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet (London Engl.)"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: Evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.7326\/L20-1206","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19","volume":"173","author":"Wichmann","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nri2956","article-title":"Platelets and the immune continuum","volume":"11","author":"Semple","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1111\/jth.15534","article-title":"Platelets contribute to disease severity in COVID-19","volume":"19","author":"Barrett","year":"2021","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"827146","DOI":"10.3389\/fimmu.2022.827146","article-title":"SARS-Cov-2 spike protein 1 activates microvascular endothelial cells and complement system leading to platelet aggregation","volume":"13","author":"Perico","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"eabh2434","DOI":"10.1126\/sciadv.abh2434","article-title":"Platelets amplify endotheliopathy in COVID-19","volume":"7","author":"Barrett","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1080\/09537104.2021.1936478","article-title":"Thrombosis in COVID-19 and non-COVID-19 pneumonia: Role of platelets","volume":"32","author":"Violi","year":"2021","journal-title":"Platelets"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jacbts.2020.12.009","article-title":"Platelet and endothelial activation as potential mechanisms behind the thrombotic complications of COVID-19 patients","volume":"6","author":"Canzano","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e150101","DOI":"10.1172\/JCI150101","article-title":"Platelets mediate inflammatory monocyte activation by SARS-Cov-2 spike protein","volume":"132","author":"Li","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19","volume":"136","author":"Hottz","year":"2020","journal-title":"Blood"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/HYPERTENSIONAHA.120.15353","article-title":"COVID-19: Ace2centric infective disease?","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Hypertension"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","article-title":"SARS-Cov-2 binds platelet ace2 to enhance thrombosis in COVID-19","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12964-020-00687-7","article-title":"Phosphatidylserine inside out: A possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19","volume":"18","author":"Palmeira","year":"2020","journal-title":"Cell Commun. Signal. CCS"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/jth.15191","article-title":"The adamts13-von willebrand factor axis in COVID-19 patients","volume":"19","author":"Mancini","year":"2021","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Iba, T., Wada, H., and Levy, J.H. (2022). Platelet activation and thrombosis in COVID-19. Semin. Seminars in Thrombosis and Hemostasis, Thieme Medical Publishers, Inc.","DOI":"10.1055\/s-0042-1749441"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2147\/JIR.S271768","article-title":"Coagulation disorders in COVID-19: Role of toll-like receptors","volume":"13","author":"Biswas","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Holcomb, D., Alexaki, A., Hernandez, N., Hunt, R., Laurie, K., Kames, J., Hamasaki-Katagiri, N., Komar, A.A., DiCuccio, M., and Kimchi-Sarfaty, C. (2021). Gene variants of coagulation related proteins that interact with SARS-Cov-2. PLoS Comput. Biol., 17.","DOI":"10.1371\/journal.pcbi.1008805"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"Corman","year":"2020","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Wang, Y., Yan, J., Shi, Y., Li, P., Liu, C., Ma, Q., Yang, R., Wang, X., Zhu, L., and Yang, X. (2009). Lack of association between polymorphisms of masp2 and susceptibility to sars coronavirus infection. BMC Infect. Dis., 9.","DOI":"10.1186\/1471-2334-9-51"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e20200199","DOI":"10.1590\/1678-4685-gmb-2020-0199","article-title":"Masps at the crossroad between the complement and the coagulation cascades\u2014The case for COVID-19","volume":"44","author":"Carvalho","year":"2021","journal-title":"Genet. Mol. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Papadopoulou, A., Musa, H., Sivaganesan, M., McCoy, D., Deloukas, P., and Marouli, E. (2021). COVID-19 susceptibility variants associate with blood clots, thrombophlebitis and circulatory diseases. PLoS ONE, 16.","DOI":"10.1101\/2021.05.04.21256617"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40001-022-00655-6","article-title":"Major coagulation disorders and parameters in COVID-19 patients","volume":"27","author":"Teimury","year":"2022","journal-title":"Eur. J. Med. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"638194","DOI":"10.3389\/fmed.2021.638194","article-title":"Abnormal coagulation function of patients with COVID-19 is significantly related to hypocalcemia and severe inflammation","volume":"8","author":"Qi","year":"2021","journal-title":"Front. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41392-021-00679-0","article-title":"The signal pathways and treatment of cytokine storm in COVID-19","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"FitzGerald, E.S., and Jamieson, A.M. (2020). Unique transcriptional changes in coagulation cascade genes in SARS-Cov-2-infected lung epithelial cells: A potential factor in COVID-19 coagulopathies. bioRxiv Prepr. Serv. Biol., preprint.","DOI":"10.1101\/2020.07.06.182972"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Arjmand, S., and Hosseinkhan, N. (2020). Identification of Potential Coagulation Pathway Abnormalities in SARS-Cov-2 Infection; Insights from Bioinformatics Analysis, Cold Spring Harbor Laboratory.","DOI":"10.1101\/2020.12.07.414631"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"20503121211002996","DOI":"10.1177\/20503121211002996","article-title":"Hypercoagulability in COVID-19: A review of the potential mechanisms underlying clotting disorders","volume":"9","author":"Alam","year":"2021","journal-title":"SAGE Open Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/jth.14960","article-title":"Fibrinolysis and COVID-19: A plasmin paradox","volume":"18","author":"Medcalf","year":"2020","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"587451","DOI":"10.3389\/fphar.2020.587451","article-title":"Prognostic genetic markers for thrombosis in COVID-19 patients: A focused analysis on d-dimer, homocysteine and thromboembolism","volume":"11","author":"Hammad","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.21037\/jtd-20-3062","article-title":"Coagulation disorders and thromboembolic disease in COVID-19: Review of current evidence in search of a better approach","volume":"13","author":"Oscullo","year":"2021","journal-title":"J. Thorac. Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e64330","DOI":"10.7554\/eLife.64330","article-title":"SARS-Cov-2 suppresses anticoagulant and fibrinolytic gene expression in the lung","volume":"10","author":"Mast","year":"2021","journal-title":"Elife"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1165\/rcmb.2021-0134ED","article-title":"Clotting in COVID-19: Is it all in the genes?","volume":"64","author":"Sin","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1515\/cclm-2021-1021","article-title":"The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors","volume":"60","author":"Vianello","year":"2021","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/17476348.2021.1916472","article-title":"Pulmonary fibrosis secondary to COVID-19: A narrative review","volume":"15","author":"Tanni","year":"2021","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Schmitt, C.A., Tchkonia, T., Niedernhofer, L.J., Robbins, P.D., Kirkland, J.L., and Lee, S. (2022). COVID-19 and cellular senescence. Nat. Rev. Immunol., ahead of print.","DOI":"10.1038\/s41577-022-00785-2"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Gujski, M., Jankowski, M., Rabczenko, D., Gory\u0144ski, P., and Juszczyk, G. (2022). The prevalence of acute respiratory distress syndrome (ards) and outcomes in hospitalized patients with COVID-19-a study based on data from the polish national hospital register. Viruses, 14.","DOI":"10.3390\/v14010076"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Ambardar, S.R., Hightower, S.L., Huprikar, N.A., Chung, K.K., Singhal, A., and Collen, J.F. (2021). Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic. J. Clin. Med., 10.","DOI":"10.3390\/jcm10112452"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"106602","DOI":"10.1016\/j.rmed.2021.106602","article-title":"Complications after discharge with COVID-19 infection and risk factors associated with development of post-COVID pulmonary fibrosis","volume":"188","author":"Aul","year":"2021","journal-title":"Respir. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijtb.2020.11.003","article-title":"Post COVID 19 pulmonary fibrosis. Is it real threat?","volume":"68","author":"Rai","year":"2021","journal-title":"Indian J. Tuberc."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Lee, I., Kim, J., Yeo, Y., Lee, J.Y., Jeong, I., Joh, J.-S., Kim, G., Chin, B.S., Kim, Y., and Kim, M.-K. (2022). Prognostic Factors for Pulmonary Fibrosis Following Pneumonia in Patients with COVID-19: A Prospective Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11195913"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"6175964","DOI":"10.1155\/2020\/6175964","article-title":"Pulmonary fibrosis in COVID-19 survivors: Predictive factors and risk reduction strategies","volume":"2020","author":"Ojo","year":"2020","journal-title":"Pulm. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/mi.2008.85","article-title":"Pulmonary fibrosis: Pathogenesis, etiology and regulation","volume":"2","author":"Wilson","year":"2009","journal-title":"Mucosal Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.4103\/lungindia.lungindia_818_20","article-title":"Post-COVID lung fibrosis: The tsunami that will follow the earthquake","volume":"38","author":"Udwadia","year":"2021","journal-title":"Lung India Off. Organ Indian Chest Soc."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11010-021-04275-2","article-title":"Role of ACE2-Ang (1-7)-Mas axis in post-COVID-19 compli-cations and its dietary modulation","volume":"477","author":"Sahu","year":"2022","journal-title":"Mol. Cell Biochem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fcimb.2020.00340","article-title":"SARS-Cov-2 pathogenesis: Imbalance in the renin-angiotensin system favors lung fibrosis","volume":"10","author":"Delpino","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Morganstein, T., Haidar, Z., Trivlidis, J., Azuelos, I., Huang, M.J., Eidelman, D.H., and Baglole, C.J. (2021). Involvement of the ACE2\/Ang-(1-7)\/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222312955"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s13054-020-03015-0","article-title":"Elevation of plasma angiotensin ii level is a potential pathogenesis for the critically ill COVID-19 patients","volume":"24","author":"Wu","year":"2020","journal-title":"Crit. Care (London Engl.)"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ace2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit. Care (London Engl.)"},{"key":"ref_112","first-page":"100023","article-title":"Converging pathways in pulmonary fibrosis and COVID-19\u2014The fibrotic link to disease severity","volume":"2","author":"Bjermer","year":"2020","journal-title":"Respir. Med. X"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Vaz de Paula, C.B., Nagashima, S., Liberalesso, V., Collete, M., da Silva, F.P.G., Oricil, A.G.G., Barbosa, G.S., da Silva, G.V.C., Wiedmer, D.B., and da Silva Dezid\u00e9rio, F. (2021). COVID-19: Immunohistochemical analysis of tgf-\u03b2 signaling pathways in pulmonary fibrosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010168"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1177\/2047487320932695","article-title":"COVID-19 and risk of pulmonary fibrosis: The importance of planning ahead","volume":"27","author":"Gentile","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"104799","DOI":"10.1016\/j.micpath.2021.104799","article-title":"The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?","volume":"153","author":"Darif","year":"2021","journal-title":"Microb. Pathog."},{"key":"ref_117","first-page":"761","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","volume":"9","author":"Xiong","year":"2020","journal-title":"SSRN Electron. J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of t cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Colarusso, C., Maglio, A., Terlizzi, M., Vitale, C., Molino, A., Pinto, A., Vatrella, A., and Sorrentino, R. (2021). Post-COVID-19 patients who develop lung fibrotic-like changes have lower circulating levels of ifn-\u03b2 but higher levels of il-1\u03b1 and tgf-\u03b2. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121931"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00408-017-9993-5","article-title":"Blood biomarkers in idiopathic pulmonary fibrosis","volume":"195","author":"Guiot","year":"2017","journal-title":"Lung"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2021.02.012","article-title":"Correlation of krebs von den lungen-6 and fibronectin with pulmonary fibrosis in coronavirus disease 2019","volume":"517","author":"Peng","year":"2021","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Arnold, D.T., Donald, C., Lyon, M., Hamilton, F.W., Morley, A.J., Attwood, M., Dipper, A., and Barratt, S.L. (2021). Krebs von den lungen 6 (kl-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0249607"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.7150\/ijbs.58825","article-title":"Krebs von den lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients","volume":"17","author":"Xue","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.virol.2021.11.006","article-title":"Krebs von den lungen-6 (kl-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses","volume":"566","author":"Naderi","year":"2022","journal-title":"Virology"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e25631","DOI":"10.1097\/MD.0000000000025631","article-title":"Can ykl-40 be used as a biomarker for interstitial lung disease? A systematic review and meta-analysis","volume":"100","author":"Tong","year":"2021","journal-title":"Medicine"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"760776","DOI":"10.3389\/fimmu.2022.760776","article-title":"Longitudinal and comparative measures of serum chitotriosidase and ykl-40 in patients with idiopathic pulmonary fibrosis","volume":"13","author":"Majewski","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13054-020-03383-7","article-title":"Ykl-40 as a new promising prognostic marker of severity in COVID infection","volume":"25","author":"Schoneveld","year":"2021","journal-title":"Crit. Care (London Engl.)"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"20638","DOI":"10.1038\/s41598-021-98253-9","article-title":"Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach","volume":"11","author":"Kimura","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1242\/dmm.012062","article-title":"Diverse functions of matrix metalloproteinases during fibrosis","volume":"7","author":"Giannandrea","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"ref_130","first-page":"847","article-title":"SARS-Cov-2 and pathological matrix remodeling mediators","volume":"70","author":"Guizani","year":"2021","journal-title":"Inflamm. Res. Off. J. Eur. Histamine Res. Soc."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"112067","DOI":"10.1016\/j.biopha.2021.112067","article-title":"Mmp-2 and mmp-9 levels in plasma are altered and associated with mortality in COVID-19 patients","volume":"142","author":"Couto","year":"2021","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.jinf.2020.06.061","article-title":"Distinct and early increase in circulating mmp-9 in COVID-19 patients with respiratory failure","volume":"81","author":"Ueland","year":"2020","journal-title":"J. Infect."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Chavez-Galan, L., Ruiz, A., Martinez-Espinosa, K., Aguilar-Duran, H., Torres, M., Falfan-Valencia, R., P\u00e9rez-Rubio, G., Selman, M., and Buendia-Roldan, I. (2022). Circulating levels of pd-l1, tim-3 and mmp-7 are promising biomarkers to differentiate COVID-19 patients that require invasive mechanical ventilation. Biomolecules, 12.","DOI":"10.3390\/biom12030445"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/12\/1845\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:37:45Z","timestamp":1760146665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/12\/1845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,10]]},"references-count":133,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["biom12121845"],"URL":"https:\/\/doi.org\/10.3390\/biom12121845","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,10]]}}}